VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer | 2 Minute Medicine
Making Choices
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials - The Lancet
.jpg "Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis")
Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis
The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor–Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women - Value in Health Regional Issues
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models | npj Breast Cancer
Why does tamoxifen work better in some women? | University of Michigan Rogel Cancer Center
Tamoxifen: what you should and shouldn't avoid - OWise UK
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology
Breast cancer treatment without tamoxifen drug - non prescription
Tamoxifen Helps Prevent Breast Cancer, but Women Reluctant to Take It
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 | Nature Communications
Tamoxifen Accelerates Endothelial Healing by Targeting ERα in Smooth Muscle Cells | Circulation Research
Medicina | Free Full-Text | Pharmacogenomics, CYP2D6, and Tamoxifen: A Survey of the Reasons Sustaining European Clinical Practice Paradigms
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial - The Lancet
Practical Steps to Prevent Breast Cancer: Day 9 - If High Risk: Consider Risk-Reducing Medications | Public Health Sciences Division | Washington University in St. Louis
mamo.cz - Tamoxifen class drugs reduce breast cancer rates by more than a third in women at high risk
Why I'm taking tamoxifen to avoid breast cancer | MD Anderson Cancer Center
Cancers | Free Full-Text | TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial | Journal of Clinical Oncology
Tamoxifen - the start of something big - Cancer Research UK - Cancer News
Why So Many of Us Quit Taking Tamoxifen | FORCE: Facing our Risk of Cancer Empowered Blog
Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an Intervention Mapping framework | SpringerLink
